Nuwellis, Inc. balance sheet
At the end of fiscal 2025, Nuwellis, Inc. had total assets of $6.1m, total liabilities of $3.5m and shareholders' equity of $2.6m. It held $1.1m in cash against $0 of debt: net cash of $1.1m.
Balance sheet
| Fiscal year | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 14 | 54 | 31 | 23 | 1 | 16 | 5 | 1 | 14 | 9 | 18 | 4 | 5 | 1 | 4 |
| Receivables | — | 0 | 0 | — | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 |
| Inventory | — | — | — | — | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
| Total current assets | 15 | 55 | 32 | 24 | 2 | 18 | 8 | 4 | 19 | 28 | 23 | 8 | 9 | 5 | 8 |
| Goodwill | — | — | — | — | 0 | 0 | — | — | — | — | — | — | — | — | — |
| Total assets | 15 | 55 | 32 | 24 | 7 | 18 | 9 | 6 | 20 | 30 | 25 | 10 | 10 | 6 | 9 |
| Accounts payable | 1 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | — | — | — | — | — |
| Deferred revenue (current) | — | — | — | — | — | 0 | — | — | — | — | — | — | — | — | — |
| Total current liabilities | 2 | 4 | 3 | 8 | 3 | 2 | 3 | 3 | 4 | 3 | 5 | 3 | 3 | 3 | 4 |
| Short-term debt | — | — | — | 4 | — | — | — | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | 4 | — | — | — | — | — | — | — | — | — | — | — |
| Total debt | 0 | 0 | 0 | 8 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 2 | 4 | 3 | 12 | 5 | 2 | 3 | 4 | 4 | 4 | 12 | 7 | 3 | 3 | 11 |
| Shareholders' equity | 13 | 52 | 29 | 12 | 2 | 16 | 6 | 2 | 16 | 26 | 12 | 3 | 7 | 3 | −2 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | — | — | 0 | — | — | — | — | — | — | 0 | — | — | — |
| Net debt (negative = net cash) | −14 | −54 | −31 | −15 | 3 | −16 | −5 | −1 | −14 | −9 | −18 | −4 | −5 | −1 | −4 |
| Shares outstanding | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 |
| Inventory | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Total current assets | 5 | 9 | 6 | 8 | 7 | 5 | 6 | 8 |
| Total assets | 7 | 10 | 7 | 9 | 8 | 6 | 7 | 9 |
| Total current liabilities | 3 | 3 | 3 | 4 | 4 | 3 | 4 | 4 |
| Total liabilities | 4 | 3 | 3 | 18 | 4 | 3 | 4 | 11 |
| Shareholders' equity | 3 | 7 | 4 | −9 | 4 | 3 | 3 | −2 |
| Shares outstanding | 2m | — | 4m | — | 1m | — | 3m | — |
Compare with peers
- Anbio Biotechnology balance sheet
- Milestone Scientific Inc. balance sheet
- Neuroone Medical Technologies Corp balance sheet
- Work Medical Technology Group LTD balance sheet
- Beyond Air, Inc. balance sheet
Head to head: NNNN vs NUWEMLSS vs NUWENMTC vs NUWENUWE vs WOK
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies